ExploreOutcomePost-treatment neurocognitive performance
Outcome

Post-treatment neurocognitive performance

Also known as: Post-treatment neurocognitive performance relative to normative population means
3 findings 1 paper 4 related entities View in graph →

Related entities

interventions
conditions
populations
studys

Findings (27)

None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49
None
decline

Survivors of pediatric ALL treated with contemporary chemotherapy performed significantly below normative population means on measures of executive functioning, verbal short-term memory, visual sustai

Effect: decline; mean = 8.05 (NEPSY-II Response Set); CI: 95% CI: 6.60-9.49

Size: mean = 8.05 (NEPSY-II Response Set) CI: 95% CI: 6.60-9.49

Papers (1)